The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
The latest report by IMARC, titled “ AlopeciaTreatmentMarket:GlobalIndustryTrends,Share,Size,Growth,OpportunityandForecast2 023-2028
” " the global alopecia treatment market size reached US$ 3.1 Billion in 2022.
Alopecia is a medical condition characterized by hair loss, which can occur on the scalp or other parts of the body. It is caused due to several factors, including a sedentary lifestyle, unhealthy eating habits, and growing stress levels. Its treatment is dependent on numerous factors, such as the type of alopecia areata, patient age, and the extent of hair loss. The treatment aims to block the immune system attack and stimulate the regrowth of hair.
Various drugs and surgical treatment options, including hair transplantation and scalp reduction, have been widely adopted for the treatment of alopecia. Besides, medications including minoxidil or finasteride are also used for baldness. These medications are formulated to stimulate hair growth or prevent further hair loss. Besides, phototherapy or low light laser therapy (LLLT) is gaining traction around the world as it is safer, tolerable, and less invasive than other treatments.
Request Free Sample Report:
https://www.imarcgroup.com/alopecia-treatment-market/requestsample
The increasing prevalence of alopecia among the masses is driving the global market. Coupled with this, the rising cases of polycystic ovary syndrome (PCOS) are contributing to the overall growth of the market. In line with this, stressful lifestyles, the escalating cases of malnutrition, and the rising number of individuals with certain medical conditions, such as diabetes, lupus, and persistent weight loss, are catalyzing the increasing risk of hair loss. Moreover, the growing awareness about hair loss and the availability of various treatment options is impacting the market favorably. Besides, the availability of advanced treatment options, including platelet-rich plasma (PRP) therapy, mesotherapy, and low-level laser therapy (LLLT)are acting as another growth-inducing factor. Along with this, the increasing availability of products, including shampoos, conditioners, and other hair care products that claim to prevent hair loss and promote hair growth is also contributing to the growth of the alopecia treatment market. Additionally, the introduction of laser caps, helmets, combs, and bands are influencing the market. Furthermore, several key players are heavily investing in research and development activities to develop novel treatment options, thus providing a boost to the market. Apart from this, the increasing availability of advanced treatment options such as stem cell therapy and gene therapy is creating a positive market outlook. The market is further driven by other factors, such as the increasing availability of advanced treatment options, continuous improvements in healthcare infrastructure, and increasing concerns among parents about the health of their children. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 4.1 Billion by 2028, exhibiting a growth rate (CAGR) of 4.75% during 2023-2028.
Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).
MarketSummary:
DrugTypeInsights:
• Minoxidil
• Finasteride
• Others
IndicationInsights:
• Androgenic Alopecia
• Alopecia Areata
• Alopecia Totalis
• Others
GenderInsights:
• Male
• Female
RouteofAdministrationInsights:
• Oral
• Topical
• Injectable
DistributionChannelInsights:
• Hospitals
• Retail Pharmacies
• Online Pharmacies
RegionalInsights:
• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
CompetitiveLandscapewithKeyPlayers:
• Aclaris Therapeutics Inc
• Cellmid Limited
• Cipla Limited
• Dr. Reddy’s Laboratories Ltd.
• GlaxoSmithKline plc
• HCell Inc.
• Johnson & Johnson
• Merck & Co. Inc.
• Pfizer Inc.
• Taisho Pharmaceutical Holdings Co. Ltd
• Teva Pharmaceutical Industries Ltd.
ViewFullReportwithTOC&ListofFigure:https://www.imarcgroup.com/alopecia-treatment-market
We are the trusted business partners to the world's leading corporates, governments, and institutions
We are the trusted business partners to the world's leading corporates, governments, and institutions
© 2019 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
